Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1780 (LINC01780) is a long non-coding RNA gene transcribed as RNA but not translated into protein[1][5]. As a member of the lincRNA family, LINC01780 is distinguished by being located in genomic regions distant from protein-coding genes and functioning primarily at the RNA level[5][3]. LincRNAs, including LINC01780, can regulate gene expression by interacting with chromatin, acting as scaffolds or guides for chromatin modifiers, or serving as decoys for RNA-binding proteins or microRNAs[3][5][7]. However, there is currently limited functional annotation or disease association specific to LINC01780, and no reported drugs directly interact with it. It is not currently recognized as a validated therapeutic target in drug development[1].
Not applicable (no known drug targeting)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1780 (LINC01780).